PTC Therapeutics (PTCT)
(Delayed Data from NSDQ)
$31.54 USD
-0.06 (-0.19%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $31.59 +0.05 (0.16%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
Earnings News For PTCT
-
PTC Therapeutics (PTCT) Reports Q2 Loss, Misses Revenue Estimates
-
PTC Therapeutics: Q2 Earnings Snapshot
-
PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
-
Will PTC Therapeutics (PTCT) Report Negative Q2 Earnings? What You Should Know
-
PTC Therapeutics: Q1 Earnings Snapshot
-
PTC Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
-
PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
PTC Therapeutics: Q4 Earnings Snapshot
-
PTC Therapeutics: Q4 Earnings Snapshot
-
PTC Therapeutics (PTCT) Reports Q4 Loss, Lags Revenue Estimates
-
PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
-
PTC Therapeutics (PTCT) to Report Q4 Results: Wall Street Expects Earnings Growth
-
PTC Therapeutics (PTCT) Reports Q3 Loss, Lags Revenue Estimates
-
PTC Therapeutics: Q3 Earnings Snapshot
-
PTC Therapeutics Provides Corporate Update and Reports Third Quarter Financial Results
-
PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
PTC Therapeutics (PTCT) Reports Q2 Loss, Misses Revenue Estimates
-
PTC Therapeutics Provides Corporate Update and Reports Second Quarter Financial Results
-
PTC Therapeutics (PTCT) Reports Q1 Loss, Tops Revenue Estimates
-
PTC Therapeutics: Q1 Earnings Snapshot
-
PTC Therapeutics Provides a Corporate Update and Reports First Quarter Financial Results
-
PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: Should You Buy?
-
PTC Therapeutics: Q4 Earnings Snapshot
-
PTC Therapeutics (PTCT) Reports Q4 Loss, Misses Revenue Estimates
-
PTC Therapeutics Provides a Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results